224 related articles for article (PubMed ID: 24621939)
21. sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T.
Emdin M; Aimo A; Vergaro G; Bayes-Genis A; Lupón J; Latini R; Meessen J; Anand IS; Cohn JN; Gravning J; Gullestad L; Broch K; Ueland T; Nymo SH; Brunner-La Rocca HP; de Boer RA; Gaggin HK; Ripoli A; Passino C; Januzzi JL
J Am Coll Cardiol; 2018 Nov; 72(19):2309-2320. PubMed ID: 30384887
[TBL] [Abstract][Full Text] [Related]
22. High-sensitivity cardiac troponin T and N-terminal pro-B-type natriuretic peptide in acute heart failure: Data from the ACE 2 study.
Berge K; Lyngbakken MN; Myhre PL; Brynildsen J; Røysland R; Strand H; Christensen G; Høiseth AD; Omland T; Røsjø H
Clin Biochem; 2021 Feb; 88():30-36. PubMed ID: 33245872
[TBL] [Abstract][Full Text] [Related]
23. Blood-Based Cardiac Biomarkers and the Risk of Cognitive Decline, Cerebrovascular Disease, and Clinical Events.
Gyanwali B; Lai MKP; Lui B; Liew OW; Venketasubramanian N; Richards AM; Chen C; Hilal S
Stroke; 2021 Jul; 52(7):2275-2283. PubMed ID: 33971742
[TBL] [Abstract][Full Text] [Related]
24. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
[TBL] [Abstract][Full Text] [Related]
25. The effects of exercise on cardiovascular biomarkers in patients with chronic heart failure.
Ahmad T; Fiuzat M; Mark DB; Neely B; Neely M; Kraus WE; Kitzman DW; Whellan DJ; Donahue M; Zannad F; Piña IL; Adams K; O'Connor CM; Felker GM
Am Heart J; 2014 Feb; 167(2):193-202.e1. PubMed ID: 24439980
[TBL] [Abstract][Full Text] [Related]
26. Association of high-sensitivity cardiac troponin T and N-terminal pro-brain-type natriuretic peptide with left ventricular structure: J-HOP study.
Hoshide S; Nagai M; Yano Y; Ishikawa J; Eguchi K; Kario K;
J Clin Hypertens (Greenwich); 2014 May; 16(5):354-61. PubMed ID: 24811391
[TBL] [Abstract][Full Text] [Related]
27. Relation of Isolated Systolic Hypertension and Pulse Pressure to High-Sensitivity Cardiac Troponin-T and N-Terminal pro-B-Type Natriuretic Peptide in Older Adults (from the Atherosclerosis Risk in Communities Study).
Madan N; Lee AK; Matsushita K; Hoogeveen RC; Ballantyne CM; Selvin E; McEvoy JW
Am J Cardiol; 2019 Jul; 124(2):245-252. PubMed ID: 31088661
[TBL] [Abstract][Full Text] [Related]
28. The Interplay between Fasting Glucose, Echocardiography, and Biomarkers: Pathophysiological Considerations and Prognostic Implications.
Pareek M
Dan Med J; 2017 Sep; 64(9):. PubMed ID: 28874244
[TBL] [Abstract][Full Text] [Related]
29. Combination of high-sensitivity troponin I and N-terminal pro-B-type natriuretic peptide predicts future hospital admission for heart failure in high-risk hypertensive patients with preserved left ventricular ejection fraction.
Okuyama R; Ishii J; Takahashi H; Kawai H; Muramatsu T; Harada M; Yamada A; Motoyama S; Matsui S; Naruse H; Sarai M; Hasegawa M; Watanabe E; Suzuki A; Hayashi M; Izawa H; Yuzawa Y; Ozaki Y
Heart Vessels; 2017 Jul; 32(7):880-892. PubMed ID: 28154958
[TBL] [Abstract][Full Text] [Related]
30. Premorbid levels of high-sensitivity cardiac troponin T and natriuretic peptide and prognosis after incident myocardial infarction.
Mok Y; Sang Y; Ballew SH; Hoogeveen RC; Ballantyne CM; Rosamond W; Coresh J; Selvin E; Matsushita K
Am Heart J; 2019 Oct; 216():62-73. PubMed ID: 31404723
[TBL] [Abstract][Full Text] [Related]
31. Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults.
deFilippi CR; de Lemos JA; Christenson RH; Gottdiener JS; Kop WJ; Zhan M; Seliger SL
JAMA; 2010 Dec; 304(22):2494-502. PubMed ID: 21078811
[TBL] [Abstract][Full Text] [Related]
32. Lung function and airway obstruction: associations with circulating markers of cardiac function and incident heart failure in older men-the British Regional Heart Study.
Wannamethee SG; Shaper AG; Papacosta O; Lennon L; Welsh P; Whincup PH
Thorax; 2016 Jun; 71(6):526-34. PubMed ID: 26811343
[TBL] [Abstract][Full Text] [Related]
33. MicroRNAs are associated with cardiac biomarkers, cardiac structure and function and incident outcomes in heart failure.
Spahillari A; Jackson L; Varrias D; Michelhaugh SA; Januzzi JL; Shahideh B; Daghfal D; Valkov N; Murtagh G; Das S
ESC Heart Fail; 2024 Jun; 11(3):1400-1410. PubMed ID: 38321808
[TBL] [Abstract][Full Text] [Related]
34. "Malignant" Left Ventricular Hypertrophy Identifies Subjects at High Risk for Progression to Asymptomatic Left Ventricular Dysfunction, Heart Failure, and Death: MESA (Multi-Ethnic Study of Atherosclerosis).
Peters MN; Seliger SL; Christenson RH; Hong-Zohlman SN; Daniels LB; Lima JAC; de Lemos JA; Neeland IJ; deFilippi CR
J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29437599
[TBL] [Abstract][Full Text] [Related]
35. Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction.
Murphy SP; Prescott MF; Maisel AS; Butler J; Piña IL; Felker GM; Ward JH; Williamson KM; Camacho A; Kandanelly RR; Solomon SD; Januzzi JL
Circ Heart Fail; 2021 Jun; 14(6):e008410. PubMed ID: 33998243
[TBL] [Abstract][Full Text] [Related]
36. Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study.
Daniels LB; Laughlin GA; Clopton P; Maisel AS; Barrett-Connor E
J Am Coll Cardiol; 2008 Aug; 52(6):450-9. PubMed ID: 18672166
[TBL] [Abstract][Full Text] [Related]
37. The Impact of Sacrubitril/Valsartan on Clinical Treatment and hs-cTnT and NT-ProBNP Serum Levels and the Left Ventricular Function in Patients with Chronic Heart Failure.
Gao Y; Xing C; Hao W; Zhao H; Wang L; Luan B; Hou A
Int Heart J; 2020 Jan; 61(1):1-6. PubMed ID: 31875616
[TBL] [Abstract][Full Text] [Related]
38. Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.
Santhanakrishnan R; Chong JP; Ng TP; Ling LH; Sim D; Leong KT; Yeo PS; Ong HY; Jaufeerally F; Wong R; Chai P; Low AF; Richards AM; Lam CS
Eur J Heart Fail; 2012 Dec; 14(12):1338-47. PubMed ID: 22869458
[TBL] [Abstract][Full Text] [Related]
39. Changes in N-terminal pro-B-type natriuretic peptide levels and outcomes in heart failure with preserved ejection fraction: an analysis of the I-Preserve study.
Jhund PS; Anand IS; Komajda M; Claggett BL; McKelvie RS; Zile MR; Carson PE; McMurray JJ
Eur J Heart Fail; 2015 Aug; 17(8):809-17. PubMed ID: 25921853
[TBL] [Abstract][Full Text] [Related]
40. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
